Evolution of Patient Concerns Regarding Safety of Gene Therapy Products in the Hemophilia Community
Time: 10:00 am
day: Day One
Details:
- The tainted blood crisis had a long-term effect on patient concerns about product safety
- This effect carries over into concerns regarding gene transfer and other newer technologies
- Adequately addressing these concerns is critical to patient acceptance and adoption of these therapies
